Cocrystal Pharma, Inc. (DUS:8CC) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock Closed: US$5M raised · US$0.9134 a share Buyers: OPKO (5,474,053 shares of common stock for $5.0 million) | Aug 3, 2026 |
| Private placement of units of common stock and unregistered warrants Closed: US$1.03M raised · US$1.39 a unit · Warrants at US$1.24 for 27 months Buyers: Phillip Frost, M.D.; Fred Hassan; Richard Pfenniger; James Martin Insiders: All four investors are insiders: directors Phillip Frost, Fred Hassan and Richard Pfenniger, and co-CEO and CFO James Martin Use of proceeds: Support clinical development programs, working capital and general corporate purposes | Oct 30, 2025 |
| Registered direct offering of shares of common stock with unregistered warrants Closed: US$4.7M raised · US$1.7 a share · Warrants at US$1.5 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Sep 15, 2025 |